InsiderClue
Insiders · Profile

Aunins John G.

Chief Technology Officer & EVP at Seres Therapeutics. Filing since 28 Mar 2016. CIK 0001643756

Company
Date
Role
Action
Shares
Amount
Of holding
MCRB Seres Therapeutics, Inc.
17 Dec 2018
Chief Technology Officer & EVP
Sold, plan not stated
14,282
$91.31K
16.0%
MCRB Seres Therapeutics, Inc.
15 Nov 2018
See Remarks
Sold, plan not stated
14,279
$117.91K
13.8%
MCRB Seres Therapeutics, Inc.
15 Oct 2018
See Remarks
Sold, plan not stated
14,279
$84.80K
12.1%
MCRB Seres Therapeutics, Inc.
17 Sep 2018
See Remarks
Sold, plan not stated
14,279
$103.88K
10.8%
MCRB Seres Therapeutics, Inc.
15 Aug 2018
See Remarks
Sold, plan not stated
14,279
$108.07K
9.7%
MCRB Seres Therapeutics, Inc.
15 Jul 2018
Chief Technology Officer & EVP
Sold, plan not stated
14,279
$115.73K
8.1%
MCRB Seres Therapeutics, Inc.
15 Jun 2018
Chief Technology Officer & EVP
Sold, plan not stated
14,279
$122.33K
7.7%
MCRB Seres Therapeutics, Inc.
15 May 2018
See Remarks
Sold, plan not stated
14,279
$115.40K
8.9%
MCRB Seres Therapeutics, Inc.
25 Apr 2018
Chief Technology Officer & EVP
Sold, plan not stated
14,279
$108.27K
7.2%
MCRB Seres Therapeutics, Inc.
26 Jan 2018
See Remarks
Sold, plan not stated
1,738
$19.15K
0.9%
MCRB Seres Therapeutics, Inc.
19 Dec 2017
Chief Technology Officer & EVP
Sold, plan not stated
1,623
$16.46K
2.7%
MCRB Seres Therapeutics, Inc.
29 Aug 2016
Chief Technology Officer & EVP
Sold, plan not stated
9,390
$102.07K
4.7%
MCRB Seres Therapeutics, Inc.
27 Jul 2016
Chief Technology Officer & EVP
Sold, plan not stated
9,250
$323.75K
4.4%
MCRB Seres Therapeutics, Inc.
25 Jul 2016
Chief Technology Officer & EVP
Sold, plan not stated
9,390
$320.95K
4.3%
MCRB Seres Therapeutics, Inc.
27 Jun 2016
Chief Technology Officer & EVP
Sold, plan not stated
9,390
$255.69K
22.3%
MCRB Seres Therapeutics, Inc.
31 May 2016
Chief Technology Officer & EVP
Sold, plan not stated
14,015
$421.09K
25.0%
MCRB Seres Therapeutics, Inc.
25 Apr 2016
Chief Technology Officer & EVP
Sold, plan not stated
18,640
$595.36K
25.0%
MCRB Seres Therapeutics, Inc.
28 Mar 2016
Chief Technology Officer & EVP
Sold, plan not stated
9,390
$224.33K
11.2%
18 decisions on file.